Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
FTV 
Fortive Corp (FTV)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/14/2025: FTV (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
20 Analysts rated it
Well-followed company, solid analyst reports, reliable data for confident investing.
1 Year Target Price $63
1 Year Target Price $63
| 6 | Strong Buy |
| 5 | Buy |
| 9 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -7.52% | Avg. Invested days 37 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 08/14/2025 |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 16.17B USD | Price to earnings Ratio 21.53 | 1Y Target Price 63 |
Price to earnings Ratio 21.53 | 1Y Target Price 63 | ||
Volume (30-day avg) 20 | Beta 1.06 | 52 Weeks Range 45.44 - 62.64 | Updated Date 08/15/2025 |
52 Weeks Range 45.44 - 62.64 | Updated Date 08/15/2025 | ||
Dividends yield (FY) 0.49% | Basic EPS (TTM) 2.22 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2025-07-30 | When Before Market | Estimate 0.59 | Actual 0.9 |
Profitability
Profit Margin 12.51% | Operating Margin (TTM) 14.63% |
Management Effectiveness
Return on Assets (TTM) 3.63% | Return on Equity (TTM) 7.36% |
Valuation
Trailing PE 21.53 | Forward PE 15.31 | Enterprise Value 19151977291 | Price to Sales(TTM) 2.63 |
Enterprise Value 19151977291 | Price to Sales(TTM) 2.63 | ||
Enterprise Value to Revenue 3.12 | Enterprise Value to EBITDA 12.14 | Shares Outstanding 338336000 | Shares Floating 319531611 |
Shares Outstanding 338336000 | Shares Floating 319531611 | ||
Percent Insiders 0.33 | Percent Institutions 100.36 |
Upturn AI SWOT
Fortive Corp
Company Overview
History and Background
Fortive Corp (FTV) was established in 2016 as a spin-off from Danaher Corporation. It focuses on industrial technology and professional instrumentation.
Core Business Areas
- Intelligent Operating Solutions: Provides workflow solutions, automation, and data connectivity to enhance operational efficiency. Includes brands like Gordian and Accruent.
- Precision Technologies: Offers sensing, test, measurement, and control solutions. Includes brands like Tektronix and Fluke.
- Advanced Healthcare Solutions: Provides medical technologies and solutions.
Leadership and Structure
James A. Lico is the CEO. Fortive operates with a decentralized structure, empowering individual business units.
Top Products and Market Share
Key Offerings
- Product Name 1: Tektronix Oscilloscopes: Electronic test and measurement devices used in engineering and research. Tektronix holds a significant share in the global oscilloscope market, estimated around 30-40%. Competitors include Keysight Technologies and Rohde & Schwarz.
- Product Name 2: Fluke Multimeters: Handheld digital multimeters used for electrical troubleshooting. Fluke is a market leader in the handheld multimeter segment. Competitors include Keysight Technologies and Hioki.
- Product Name 3: Gordian: Offers construction cost data and estimating software. Competitors include RSMeans and BNi Building News.
Market Dynamics
Industry Overview
The industrial technology market is driven by automation, digitalization, and increasing demand for efficiency. The healthcare technology market is driven by an aging population and increasing needs for sophisticated patient care.
Positioning
Fortive is well-positioned to benefit from these trends with its diversified portfolio and focus on innovation.
Total Addressable Market (TAM)
The company operates in several markets totaling over $100 billion. Fortive is positioned to capture growth within each sector.
Upturn SWOT Analysis
Strengths
- Diversified portfolio
- Strong brand reputation
- Decentralized operating model
- Focus on innovation
- Strong cash flow generation
Weaknesses
- Dependence on macroeconomic conditions
- Exposure to cyclical industries
- Integration risks from acquisitions
- Exposure to currency fluctuations
Opportunities
- Growing demand for automation
- Increasing digitalization
- Expansion into emerging markets
- Strategic acquisitions
- Increasing healthcare spend
Threats
- Economic downturns
- Increased competition
- Technological obsolescence
- Regulatory changes
- Supply chain disruptions
Competitors and Market Share
Key Competitors
- KEYS
- ROH
- HON
- EMR
Competitive Landscape
Fortive benefits from its diversified portfolio and strong brand reputation. However, it faces competition from larger, more established players in some segments.
Major Acquisitions
Provation
- Year: 2021
- Acquisition Price (USD millions): 1430
- Strategic Rationale: Expanded its healthcare solutions offerings.
Growth Trajectory and Initiatives
Historical Growth: Fortive has grown both organically and through acquisitions.
Future Projections: Analysts project continued revenue growth and margin expansion.
Recent Initiatives: Strategic acquisitions to expand product portfolio and market reach. Focus on digital transformation.
Summary
Fortive is a strong industrial technology company with a diversified portfolio and a focus on innovation. Its decentralized operating model allows it to respond quickly to changing market conditions. However, the company is exposed to cyclical industries and integration risks from acquisitions. Overall, Fortive appears fundamentally sound.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Filings (10-K, 10-Q)
- Earnings Transcripts
- Analyst Reports
- Market Research Reports
Disclaimers:
This analysis is for informational purposes only and should not be considered financial advice. Past performance is not indicative of future results. Market conditions and company-specific events can significantly impact investment outcomes.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Fortive Corp
Exchange NYSE | Headquaters Everett, WA, United States | ||
IPO Launch date 2016-07-01 | President, CEO & Director Mr. Olumide Soroye J.D. | ||
Sector Technology | Industry Scientific & Technical Instruments | Full time employees 18000 | Website https://www.fortive.com |
Full time employees 18000 | Website https://www.fortive.com | ||
Fortive Corporation designs, develops, manufactures, and markets products, software, and services in the United States, China, and internationally. It operates through Intelligent Operating Solutions and Advanced Healthcare Solutions segments. The Intelligent Operating Solutions segment provides advanced instrumentation, software, and services, including electrical test and measurement, facility and asset lifecycle software applications, and connected worker safety and compliance solutions for manufacturing, process industries, healthcare, utilities and power, communications and electronics, and other industries. This segment markets its products and services under the ACCRUENT, FLUKE, GORDIAN, INDUSTRIAL SCIENTIFIC, INTELEX, PRUFTECHNIK, and SERVICECHANNEL brand names. The Advanced Healthcare Solutions segment provides critical workflow solutions comprising instrument sterilization, instrument tracking, design and manufacture of cell therapy equipment, biomedical test tools, radiation detection and safety monitoring, and end-to-end clinical productivity software and solutions under the ASP, CENSIS, CENSITRAC, EVOTECH, FLUKE BIOMEDICAL, INVETECH, LANDAUER, PROVATION, RAYSAFE, and STERRAD brand names. Fortive Corporation was incorporated in 2015 and is headquartered in Everett, Washington.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.